UCLA epidemiologist Robert Kim-Farley reflects on how the U.S. has coped with the pandemic
When Robert Kim-Farley heard that COVID-19 had reached the United States, on Jan. 20, 2020, he immediately recalled the grim images from China that he had been seeing online, with people dying in the streets outside of overwhelmed hospitals. (more…)
ANN ARBOR — University of Michigan scientists and their colleagues used glowing fluorescent gel to test the potential effectiveness of vaccines to control rabies and other diseases in wild bats. (more…)
Initial, positive results have been reported for a therapeutic vaccine candidate for treating patients with genital herpes. This first-in-class, investigational, protein subunit vaccine, GEN-003, is under development by Genocea Biosciences Inc.
Dr. Anna Wald, University of Washington professor of medicine and laboratory medicine in the School of Medicine and professor of epidemiology in the School of Public Health, is among those leading clinical studies of GEN-003. The trials are also taking place at six other centers in the United States. (more…)
Like malaria, dengue fever is an infectious disease transmitted by mosquitoes. Unlike malaria, there is no vaccine for it. As many as 100 million people contract dengue each year, but MSU researcher Zhiyong Xi is working to change that.
Among the estimated 2.5 billion people at risk for dengue, more than 70 percent live in Asia Pacific countries, which spurred Xi to establish a collaborative research institute at Sun Yat-sen University in Guangzhou, China. (more…)
The only way to protect against HIV and unintended pregnancy today is the condom. It’s an effective technology, but not appropriate or popular in all situations.
A University of Washington team has developed a versatile platform to simultaneously offer contraception and prevent HIV. Electrically spun cloth with nanometer-sized fibers can dissolve to release drugs, providing a platform for cheap, discrete and reversible protection. (more…)
Microsoft Research develops biometric monitoring system to help patients complete tuberculosis treatment programs.
BANGALORE, India — Dec. 3, 2012 — Giri Prasad, a 33-year-old tailor who lives in Delhi, first noticed the pain below his ribs. He went to see a doctor, but when it didn’t subside, he traveled to the hospital where he eventually learned he had tuberculosis.
“There were many problems because first and foremost, I am the bread earner for the family,” he says. “If the bread earner falls ill, it is a real problem for those who are dependent on him. Here in the city the biggest problem is that if one falls sick, there is no other person who will come help.” (more…)
ANN ARBOR, Mich.— Childhood vaccines do not cause autism. President Obama was born in the United States. Global warming is confirmed by science. And yet, many people believe claims to the contrary.
In a study appearing in the current issue of Psychological Science in the Public Interest, researchers from the University of Michigan, University of Western Australia and University of Queensland examined factors that cause people to resist correcting misinformation.
Misinformation can originate from rumors but also fiction, government and politicians, and organizations, the researchers say. (more…)
EAST LANSING, Mich. — Continuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine – one that combines the use of a disabled cold virus with an immune system-stimulating gene – that appears to increase the immune response against the parasite that causes the deadly disease.
At the same time, the group led by Andrea Amalfitano of the College of Osteopathic Medicine also discovered another immune-system stimulating agent – created at MSU and which has been successful in improving immune responses in vaccines for diseases such as HIV – paradoxically made for a less effective malaria vaccine. (more…)
